IL6 and COVID-19: Michalakis and colleagues illustrated that activated NF-κB signaling pathway in COVID-19 triggers release of IL-6, aldosterone and vascular endothelial growth factor (VEGF) from adipose tissue in obese patients with subsequent development of hypertension [63].